S. 2529
Introduced in Senate · August 7, 2025July 30, 2025
Mr. Husted (for himself and Ms. Hassan) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
A BILL
To increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Increasing the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.
- (a) In general.—Section 505(b) of the Federal Food, Drug, and Cosmetic Act is amended by adding at the end the following: